v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Underwritten Offering
Common Stock
Common Stock
Underwritten Offering
Additional Paid-in Capital
Additional Paid-in Capital
Underwritten Offering
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance, shares at Dec. 31, 2024     283,218,344          
Beginning balance at Dec. 31, 2024 $ 423,499   $ 28   $ 1,190,729   $ 405 $ (767,663)
Exercise of stock options, shares     47,372          
Exercise of stock options 33       33      
Stock-based compensation expense 6,713       6,713      
Net loss (30,966)             (30,966)
Unrealized gain (loss) on marketable securities, net 223           223  
Ending balance, shares at Mar. 31, 2025     283,265,716          
Ending balance at Mar. 31, 2025 $ 399,502   $ 28   1,197,475   628 (798,629)
Beginning balance, shares at Dec. 31, 2025 284,159,076   284,159,076          
Beginning balance at Dec. 31, 2025 $ 325,171   $ 28   1,216,724   628 (892,209)
Issuance of common stock   $ 242,706   $ 3   $ 242,703    
Issuance of common stock, share       25,875,000        
Exercise of stock options, shares     772,812          
Exercise of stock options 1,958       1,958      
Stock-based compensation expense 8,460       8,460      
Net loss (183,440)             (183,440)
Unrealized gain (loss) on marketable securities, net $ (1,327)           (1,327)  
Ending balance, shares at Mar. 31, 2026 310,806,888   310,806,888          
Ending balance at Mar. 31, 2026 $ 393,528   $ 31   $ 1,469,845   $ (699) $ (1,075,649)